The Global Artificial Lung Market Size Was Worth Around USD 2.45 Billion In 2024 And Is Predicted To Grow To Around USD 6.67 Billion By 2035 With A Compound Annual Growth Rate (CAGR) Of 9.53 % From 2025 To 2035.
Artificial lungs play an essential role in medical treatment for ARDS and COPD patients who need lung transplant procedures. The demand for these devices, which medical facilities use in ICUs, surgical centers and transplant programs, has increased because healthcare expenditures have risen, and people have become more aware of organ support technologies and their application of ECMO for critical care treatment after the COVID-19 pandemic.
This comprehensive market research report provides an in-depth analysis of the Artificial Lung market, with a focused evaluation of industry developments through 2025. The study delivers detailed insights into current market dynamics, emerging trends, growth drivers, competitive landscape, future strategic outlook, and the evolving regulatory key segments.
The Global Artificial Lung Market Report identifies emerging business opportunities while supporting informed strategic and tactical decision-making. Designed for stakeholders operating in a highly competitive and rapidly evolving landscape, this study delivers up-to-date market intelligence essential for tracking performance, mitigating risks, and driving sustainable growth and profitability.
- Abbott Laboratories
- Abiomed (Johnson and Johnson MedTech)
- ALung Technologies, Inc.
- Braile Biomédica
- Getinge AB
- Hemovent GmbH
- LivaNova PLC
- MC3 Cardiopulmonary
- Medtronic plc
- MicroPort Scientific Corporation
- Nipro Corporation
- Novalung GmbH (a Xenios company)
- Xenios AG (Fresenius Medical Care)
- Others
Our expert team is consistently working on updated data and information on the key player's related business processes that value the market for future strategies and predictions
Get Access to a Free Copy of Our Latest Sample Report - https://www.decisionsadvisors.com/request-sample/DAR4483
Market Segmentation:
By Product Type
- Extracorporeal Membrane Oxygenation (ECMO) Systems
- Paracorporeal Artificial Lungs
- Intracorporeal Artificial Lungs
- Membrane Oxygenators
- Portable Artificial Lungs
By Application
- Bridge-to-Transplantation
- Bridge-to-Recovery
- ECMO-assisted Ventilation
- Pulmonary Rehabilitation
- Long-term Support for Chronic Lung Diseases
Key Players Detail:
In-depth competitive benchmarking analysis of the Artificial Lung Market, covering company market share, innovation strategies, product development, geographic expansion, and strategic partnerships shaping the industry landscape.
Abbott Laboratories Abiomed (Johnson and Johnson MedTech) ALung Technologies, Inc. Braile Biomédica Getinge AB Hemovent GmbH LivaNova PLC MC3 Cardiopulmonary Medtronic plc MicroPort Scientific Corporation Nipro Corporation Novalung GmbH (a Xenios company) Xenios AG (Fresenius Medical Care) Others
Key Insights Covered in the Global Artificial Lung Market Size & Industry Forecast Report (2020–2035):
1. Detailed analysis of the Global Artificial Lung Market Size, production capacity, utilization rate, output trends, capital investment patterns, and regulatory landscape, along with comprehensive profiles of leading market players.
2. Thorough assessment of Artificial Lung Market Growth, revenue analysis, historical performance, and forward-looking projections across major regional markets.
3. In-depth Artificial Lung Industry Analysis covering competitive landscape, company market share, pricing trends, and future opportunity mapping.
4. Strategic evaluation of recent developments including mergers & acquisitions, partnerships, collaborations, joint ventures, geographic expansions, and product launches shaping the Artificial Lung Market Share.
5. Comprehensive value chain and supply chain analysis highlighting raw material sourcing, distribution channels, and end-user segmentation.
6. Regional regulatory framework assessment and policy impact analysis influencing the Artificial Lung Industry Forecast across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
7. Coverage of technological advancements, product innovations, R&D investments, automation trends, and digital transformation influencing long-term Global Artificial Lung Market Growth.
Buy this report now:- https://www.decisionsadvisors.com/checkout/select-licence?report_id=DAR4483
Industry Developments:
In January 2026, Northwestern Medicine surgeons achieved a remarkable milestone by developing a total artificial lung (TAL) system that kept a patient alive for 48 hours without lungs, enabling a successful double-lung transplant. The patient received a double-lung transplant and has since recovered well, with fully functioning lungs.
In December 2024, Carnegie Mellon University (CMU) researchers played a central role in a DARPA-funded project to advance artificial lung technology for military and emergency applications. DARPA awarded $18 million to a multi-institutional team that includes CMU’s Keith Cook (Biomedical Engineering).
Regional Analysis for Artificial Lung Market:
✫ North America: (U.S., Canada, Mexico)
✫ Europe: (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific: (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America: (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa: (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
⏩ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
⏩ Top-down and bottom-up approach for regional analysis
⏩ Porter’s five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
⏩ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Insightful inquiry before buying:- https://www.decisionsadvisors.com/request-customization/DAR4483
Frequently asked questions:
➥ What is the market size of the Artificial Lung market?
➥ What is the market growth rate of the Artificial Lung market?
➥ What are the Artificial Lung market opportunities and threats faced by the vendors in the global Artificial Lung Industry?
➥ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➥ What focused approach and constraints are holding the Artificial Lung market?
➥ What are the different sales, marketing, and distribution channels in the global industry?
Unlock the full report now! @ https://www.decisionsadvisors.com/reports/artificial-lung-market
About the Decisions Advisors
Decisions Advisors is a comprehensive market research and consulting company that provides actionable insights based on data. We deal with businesses from various industries and deliver a market intelligence, competitive analysis, forecasting, and bespoke consulting. We also conduct bespoke consulting for our clients.
We provides well-supported advice and intelligence on how businesses can operate in a given market and succeed in achieving their goals.
Contact Us:
Company Name: Decision Advisors
Email: sales@sphericalinsights.com
Phone: +1 303 800 4326 (US)
